Vibrio cholerae virulence and its suppression through the quorum-sensing system

References

• Absalon C, Van Dellen K, Watnick PI. 2011. A communal bacterial adhesin anchors biofilm and bystander cells to surfaces. PLoS Pathog. 7(8):e1002210. doi:10.1371/journal.ppat.1002210.
   Google Scholar
• Ali M, Nelson AR, Lopez AL, Sack DA. 2015. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 9(6):e0003832. doi:10.1371/journal.pntd.0003832.
   PubMed Web of Science ®Google Scholar
• Ali M, Nelson A, Luquero FJ, Azman AS, Debes AK, M’bang’ombe MM, Seyama L, Kachale E, Zuze K, Malichi D, et al. 2017. Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study. Lancet Infect Dis. 17(5):538–544. doi:10.1016/S1473-3099(16)30523-0.
   PubMed Web of Science ®Google Scholar
• Almagro-Moreno S, Pruss K, Taylor RK. 2015. Intestinal colonization dynamics of Vibrio cholerae. PLoS Pathog. 11(5):e1004787. doi:10.1371/journal.ppat.1004787.
   PubMed Web of Science ®Google Scholar
• Anthouard R, DiRita VJ. 2013. Small-molecule inhibitors of toxT expression in Vibrio cholerae. MBio. 4(4):13. doi:10.1128/mBio.00403-13.
   Web of Science ®Google Scholar
• Attridge SR, Voss E, Manning PA. 1999. Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae El Tor. J Biotechnol. 73(2–3):109–117. doi:10.1016/S0168-1656(99)00114-5.
   PubMed Web of Science ®Google Scholar
• Augustine N, Goel AK, Sivakumar KC, Kumar RA, Thomas S. 2014. Resveratrol–a potential inhibitor of biofilm formation in Vibrio cholerae. Phytomedicine. 21(3):286–289. doi:10.1016/j.phymed.2013.09.010.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay P, Sathe M, Ponmariappan S, Sharma A, Sharma P, Srivastava AK, Kaushik MP. 2011. Exploration of in vitro time point quantitative evaluation of newly synthesized benzimidazole and benzothiazole derivatives as potential antibacterial agents. Bioorg Med Chem Lett. 21(24):7306–7309. doi:10.1016/j.bmcl.2011.10.034.
   PubMed Web of Science ®Google Scholar
• Bersani C, Berna M, Pasut G, Veronese FM. 2005. PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties. Farmaco. 60(9):783–788. doi:10.1016/j.farmac.2005.04.015.
   PubMedGoogle Scholar
• Bénitez JA, Spelbrink RG, Silva A, Phillips TE, Stanley CM, Boesman-Finkelstein M, Finkelstein RA. 1997. Adherence of Vibrio cholerae to cultured differentiated human intestinal cells: an in vitro colonization model. Infect Immun. 65(8):3474–3477. doi:10.1128/iai.65.8.3474-3477.1997.
   PubMed Web of Science ®Google Scholar
• Berk V, Fong JCN, Dempsey GT, Develioglu ON, Zhuang X, Liphardt J, Yildiz FH, Chu S. 2012. Molecular architecture and assembly principles of Vibrio cholerae biofilms. Science. 337(6091):236–239. doi:10.1126/science.1222981.
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Sinha R, Mukherjee P, Howlader DR, Nag D, Sarkar S, Koley H, Withey JH, Gachhui R. 2020. Anti-virulence activity of polyphenolic fraction isolated from Kombucha against Vibrio cholerae. Microb Pathog. 140:103927. doi:10.1016/j.micpath.2019.103927.
   PubMed Web of Science ®Google Scholar
• Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, Qadri F, Digilio L, Sack DA, Ali M, et al. 2017. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 17(10):1080–1088. doi:10.1016/S1473-3099(17)30359-6.
   PubMed Web of Science ®Google Scholar
• Bina XR, Provenzano D, Nguyen N, Bina JE. 2008. Vibrio cholerae RND Family Efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect Immun. 76(8):3595–3605. doi:10.1128/IAI.01620-07.
   PubMed Web of Science ®Google Scholar
• Bina XR, Howard MF, Taylor-Mulneix DL, Ante VM, Kunkle DE, Bina JE. 2018. The Vibrio cholerae RND efflux systems impact virulence factor production and adaptive responses via periplasmic sensor proteins. PLoS Pathog. 14(1):e1006804. doi:10.1371/journal.ppat.1006804.
   PubMed Web of Science ®Google Scholar
• Borgeaud S, Metzger LC, Scrignari T, Blokesch M. 2015. The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer. Science. 347(6217):63–67. doi:10.1126/science.1260064.
   PubMed Web of Science ®Google Scholar
• Boyaci H, Shah T, Hurley A, Kokona B, Li Z, Ventocilla C, Jeffrey PD, Semmelhack MF, Fairman R, Bassler BL, et al. 2016. Structure, regulation, and inhibition of the quorum-sensing signal integrator LuxO. PLoS Biol. 14(5):e1002464. doi:10.1371/journal.pbio.1002464.
   PubMed Web of Science ®Google Scholar
• Bridges AA, Bassler BL. 2019. The intragenus and interspecies quorum-sensing autoinducers exert distinct control over Vibrio cholerae biofilm formation and dispersal. PLoS Biol. 17(11):e3000429. doi:10.1371/journal.pbio.3000429.
   PubMed Web of Science ®Google Scholar
• Butler SM, Camilli A. 2005. Going against the grain: chemotaxis and infection in Vibrio cholerae. Nat Rev Microbiol. 3(8):611–620. doi:10.1038/nrmicro1207.
   PubMed Web of Science ®Google Scholar
• Caigoy JC, Shimamoto T, Mukhopadhyay AK, Shinoda S, Shimamoto T. 2022. Sequence polymorphisms in Vibrio cholerae HapR affect biofilm formation under aerobic and anaerobic conditions. Appl Environ Microbiol. 88(17):e0104422. doi:10.1128/aem.01044-22.
   PubMed Web of Science ®Google Scholar
• Cameron DE, Urbach JM, Mekalanos JJ. 2008. A defined transposon mutant library and its use in identifying motility genes in Vibrio cholerae. Proc Natl Acad Sci USA. 105(25):8736–8741. doi:10.1073/pnas.0803281105.
   PubMed Web of Science ®Google Scholar
• Carvalho A, Krin E, Korlowski C, Mazel D, Baharoglu Z. 2021. Interplay between Sublethal Aminoglycosides and Quorum Sensing: consequences on Survival in V. cholerae. Cells. 10(11):3227. doi:10.3390/cells10113227.
   PubMed Web of Science ®Google Scholar
• Chaand M, Dziejman M. 2013. Vibrio cholerae VttR A and VttR B regulatory influences extend beyond the type 3 secretion system genomic Island. J Bacteriol. 195(10):2424–2436. doi:10.1128/JB.02151-12.
   PubMed Web of Science ®Google Scholar
• Chaand M, Miller KA, Sofia MK, Schlesener C, Weaver JW, Sood V, Dziejman M. 2015. Type 3 secretion system island encoded proteins required for colonization by non-o1/non-o139 serogroup Vibrio cholerae. Infect Immun. 83(7):2862–2869. doi:10.1128/IAI.03020-14.
   PubMed Web of Science ®Google Scholar
• Chatterjee P, Kanungo S, Bhattacharya SK, Dutta S. 2020. Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: an assessment of existing data and a scoping review of the literature. Vaccine. 38(Suppl 1):A93–A104. doi:10.1016/j.vaccine.2019.12.003.
   PubMedGoogle Scholar
• Chatterjee T, Saha T, Sarkar P, Hoque KM, Chatterjee BK, Chakrabarti P. 2021. The gold nanoparticle reduces Vibrio cholerae. pathogenesis by inhibition of biofilm formation and disruption of the production Colloids and Surfaces B: Biointerfaces 204 (2021): 111811.
   Google Scholar
• Chatterjee S, Asakura M, Chowdhury N, Neogi SB, Sugimoto N, Haldar S, Awasthi SP, Hinenoya A, Aoki S, Yamasaki S. 2010. Capsaicin, a potential inhibitor of cholera toxin production in Vibrio cholerae. FEMS Microbiol Lett. 306(1):54–60. doi:10.1111/j.1574-6968.2010.01931.x.
   PubMed Web of Science ®Google Scholar
• Chatterjee SN, Chaudhuri K. 2003. Lipopolysaccharides of Vibrio cholerae. Biochim Biophys Acta. 1639(2):65–79. doi:10.1016/j.bbadis.2003.08.004.
   PubMed Web of Science ®Google Scholar
• Cheng AT, Ottemann KM, Yildiz FH. 2015. Vibrio cholerae response regulator VxrB controls colonization and regulates the type VI secretion system. PLoS Pathog. 11(5):e1004933. doi:10.1371/journal.ppat.1004933.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang R, Chen A, Wang Y, Wang Y, Zhou J, Cao R. 2019. Inhibition of mouse RM-1 prostate cancer and B16F10 melanoma by the fusion protein of HSP65 & STEAP1 186-193. Biomed Pharmacother. 111:1124–1131. doi:10.1016/j.biopha.2019.01.012.
   PubMed Web of Science ®Google Scholar
• Chiavelli DA, Marsh JW, Taylor RK. 2001. The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton. Appl Environ Microbiol. 67(7):3220–3225. doi:10.1128/AEM.67.7.3220-3225.2001.
   PubMed Web of Science ®Google Scholar
• Chinnapen DJ-F, Chinnapen H, Saslowsky D, Lencer WI. 2007. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol Lett. 266(2):129–137. doi:10.1111/j.1574-6968.2006.00545.x.
   PubMed Web of Science ®Google Scholar
• Chowdhury FR, Nur Z, Hassan N, von Seidlein L, Dunachie S. 2017. Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming. Ann Clin Microbiol Antimicrob. 16(1):10. doi:10.1186/s12941-017-0185-1.
   PubMedGoogle Scholar
• Clatworthy AE, Pierson E, Hung DT. 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 3(9):541–548. doi:10.1038/nchembio.2007.24.
   PubMed Web of Science ®Google Scholar
• Coburn B, Sekirov I, Finlay BB. 2007. Type III secretion systems and disease. Clin Microbiol Rev. 20(4):535–549. doi:10.1128/CMR.00013-07.
   PubMed Web of Science ®Google Scholar
• Dalsgaard A, Forslund A, Bodhidatta L, Serichantalergs O, Pitarangsi C, Pang L, Shimada T, Echeverria P. 1999. A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes. Epidemiol Infect. 122(2):217–226. doi:10.1017/s0950268899002137.
   PubMed Web of Science ®Google Scholar
• Das B, Verma J, Kumar P, Ghosh A, Ramamurthy T. 2020. Antibiotic resistance in Vibrio cholerae: understanding the ecology of resistance genes and mechanisms. Vaccine. 38(Suppl 1):A83–A92. doi:10.1016/j.vaccine.2019.06.031.
   PubMedGoogle Scholar
• Davis BM, Waldor MK. 2003. Filamentous phages linked to virulence of Vibrio cholerae. Curr Opin Microbiol. 6(1):35–42. doi:10.1016/S1369-5274(02)00005-X.
   PubMed Web of Science ®Google Scholar
• Dengo-Baloi LC, Semá-Baltazar CA, Manhique LV, Chitio JE, Inguane DL, Langa JP. 2017. Antibiotics resistance in El Tor Vibrio cholerae O1 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PLoS One. 12(8):e0181496. doi:10.1371/journal.pone.0181496.
   PubMed Web of Science ®Google Scholar
• DiRita VJ, Mekalanos JJ. 1991. Periplasmic interaction between two membrane regulatory proteins, ToxR and ToxS, results in signal transduction and transcriptional activation. Cell. 64(1):29–37. doi:10.1016/0092-8674(91)90206-E.
   PubMed Web of Science ®Google Scholar
• DiRita VJ, Parsot C, Jander G, Mekalanos JJ. 1991. Regulatory cascade controls virulence in Vibrio cholerae. Proc Natl Acad Sci USA. 88(12):5403–5407. doi:10.1073/pnas.88.12.5403.
   PubMed Web of Science ®Google Scholar
• Dolores JS, Agarwal S, Egerer M, Satchell KJF. 2015. Vibrio cholerae MARTX toxin heterologous translocation of beta-lactamase and roles of individual effector domains on cytoskeleton dynamics. Mol Microbiol. 95(4):590–604. doi:10.1111/mmi.12879.
   PubMed Web of Science ®Google Scholar
• Dolores J, Satchell KJF. 2013. Analysis of Vibrio cholerae genome sequences reveals unique rtxa variants in environmental strains and an rtxA -null mutation in recent altered El Tor isolates. MBio. 4(2):12. doi:10.1128/mBio.00624-12.
   Web of Science ®Google Scholar
• Domalaon R, Idowu T, Zhanel GG, Schweizer F. 2018. Antibiotic hybrids: the next generation of agents and adjuvants against Gram-negative pathogens? Clin Microbiol Rev. 31(2):17. doi:10.1128/CMR.00077-17.
   Web of Science ®Google Scholar
• Dua P, Karmakar A, Ghosh C. 2018. Virulence gene profiles, biofilm formation, and antimicrobial resistance of Vibrio cholerae non-O1/non-O139 bacteria isolated from West Bengal, India. Heliyon. 4(12):e01040. doi:10.1016/j.heliyon.2018.e01040.
   PubMedGoogle Scholar
• Erfanimanesh S, Eslami G, Taherpour A, Hashemi A. 2019. Capsaicin inhibitory effects on Vibrio cholerae toxin genes expression. Avicenna J Phytomed. 9(3):187–194.
   PubMed Web of Science ®Google Scholar
• Faloon P, Youngsaye W, Bennion M, Ng WL, Hurley A, Lewis TA, Edwankar RV, Yao E, Pu J, Nag PP, et al. 2013. Discovery of two, structurally distinct agonists of Vibrio cholerae quorum sensing acting via the CqsS membrane receptor. Probe Reports from the NIH Molecular Libraries Program. [Internet].
   Google Scholar
• Faruque SM, Mekalanos JJ. 2003. Pathogenicity islands and phages in Vibrio cholerae evolution. Trends Microbiol. 11(11):505–510. doi:10.1016/j.tim.2003.09.003.
   PubMed Web of Science ®Google Scholar
• Faruque, Shah M, Kamruzzaman, M, Sack, David A, Mekalanos, John J, Nair, G Balakrish, Asadulghani, (2003). CTXΦ-independent production of the RS1 satellite phage by Vibrio cholerae. Proc Natl Acad Sci USA, 100(3), 1280–1285. doi:10.1073/pnas.0237385100.
   PubMed Web of Science ®Google Scholar
• Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB. 1991. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA. 88(12):5242–5246. doi:10.1073/pnas.88.12.5242.
   PubMed Web of Science ®Google Scholar
• Figueroa-Arredondo P, Heuser JE, Akopyants NS, Morisaki JH, Giono-Cerezo S, Enríquez-Rincón F, Berg DE. 2001. Cell vacuolation caused by Vibrio cholerae hemolysin. Infect Immun. 69(3):1613–1624. doi:10.1128/IAI.69.3.1613-1624.2001.
   PubMed Web of Science ®Google Scholar
• Fleitas Martínez O, Cardoso MH, Ribeiro SM, Franco OL. 2019. Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front Cell Infect Microbiol. 9:74. doi:10.3389/fcimb.2019.00074.
   PubMed Web of Science ®Google Scholar
• Floyd KA, Lee CK, Xian W, Nametalla M, Valentine A, Crair B, Zhu S, Hughes HQ, Chlebek JL, Wu DC, et al. 2020. c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in Vibrio cholerae. Nat Commun. 11(1):1549. doi:10.1038/s41467-020-15331-8.
   PubMed Web of Science ®Google Scholar
• Fong JCN, Syed KA, Klose KE, Yildiz FH. 2010. Role of Vibrio polysaccharide (vps) genes in VPS production, biofilm formation and Vibrio cholerae pathogenesis. Microbiology. 156(Pt 9):2757–2769. doi:10.1099/mic.0.040196-0.
   PubMedGoogle Scholar
• Fu Y, Waldor MK, Mekalanos JJ. 2013. Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell Host Microbe. 14(6):652–663. doi:10.1016/j.chom.2013.11.001.
   PubMed Web of Science ®Google Scholar
• Fullner KJ, Lencer WI, Mekalanos JJ. 2001. Vibrio cholerae-induced cellular responses of polarized T84 intestinal epithelial cells are dependent on production of cholera toxin and the RTX toxin. Infect Immun. 69(10):6310–6317. doi:10.1128/IAI.69.10.6310-6317.2001.
   PubMed Web of Science ®Google Scholar
• Gao H, Zhang J, Lou J, Li J, Qin Q, Shi Q, Zhang Y, Kan B. 2020. Direct binding and regulation by Fur and HapR of the intermediate regulator and virulence factor genes within the ToxR virulence regulon in Vibrio cholerae. Front Microbiol. 11:709. doi:10.3389/fmicb.2020.00709.
   PubMed Web of Science ®Google Scholar
• Garbern SC, Chu T-C, Yang P, Gainey M, Nasrin S, Kanekar S, Qu K, Nelson EJ, Leung DT, Ahmed D, et al. 2021. Clinical and socio-environmental determinants of multidrug-resistant Vibrio cholerae O1 in older children and adults in Bangladesh. Int J Infect Dis. 105:436–441. doi:10.1016/j.ijid.2021.02.102.
   PubMed Web of Science ®Google Scholar
• Garland M, Loscher S, Bogyo M. 2017. Chemical strategies to target bacterial virulence. Chem Rev. 117(5):4422–4461. doi:10.1021/acs.chemrev.6b00676.
   PubMed Web of Science ®Google Scholar
• Geissler B, Ahrens S, Satchell KJF. 2012. Plasma membrane association of three classes of bacterial toxins is mediated by a basic-hydrophobic motif. Cell Microbiol. 14(2):286–298. doi:10.1111/j.1462-5822.2011.01718.x.
   PubMed Web of Science ®Google Scholar
• Geissler B, Tungekar R, Satchell KJF. 2010. Identification of a conserved membrane localization domain within numerous large bacterial protein toxins. Proc Natl Acad Sci USA. 107(12):5581–5586. doi:10.1073/pnas.0908700107.
   PubMed Web of Science ®Google Scholar
• Gerdes JC, Romig WR. 1975. Genetic basis of toxin production and pathogenesis in Vibrio cholerae: evidence against phage conversion. Infect Immun. 11(3):445–452. doi:10.1128/iai.11.3.445-452.1975.
   PubMed Web of Science ®Google Scholar
• Gholizadeh Tangestani M, Alinezhad J, Khajeian A, Gharibi S, Haghighi MA. 2020. Identification of cholix toxin gene in. Vibrio cholerae. Iranian Journal of Microbiology 12(4):273.
   Google Scholar
• Ghosh A, Ramamurthy T. 2011. Antimicrobials & cholera: are we stranded? Indian J Med Res. 133(2):225–231.
   PubMed Web of Science ®Google Scholar
• Gmeiner J, Lüderitz O, Westphal O. 1969. Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component. Eur J Biochem. 7(3):370–379. doi:10.1111/j.1432-1033.1969.tb19618.x.
   PubMedGoogle Scholar
• Gupta P, Mankere B, Chekkoora Keloth S, Tuteja U, Pandey P, Chelvam KT. 2018. Increased antibiotic resistance exhibited by the biofilm of Vibrio cholerae O139. J Antimicrob Chemother. 73(7):1841–1847. doi:10.1093/jac/dky127.
   PubMed Web of Science ®Google Scholar
• Halpern M. 2010. Novel insights into Haemagglutinin Protease (HAP) gene regulation in Vibrio cholerae. Mol Ecol. 19(19):4108–4112. doi:10.1111/j.1365-294X.2010.04809.x.
   PubMed Web of Science ®Google Scholar
• Hammer BK, Bassler BL. 2003. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol Microbiol. 50(1):101–104. doi:10.1046/j.1365-2958.2003.03688.x.
   PubMed Web of Science ®Google Scholar
• He X, Yang J, Ji M, Chen Y, Chen Y, Li H, Wang H. 2022. A potential delivery system based on cholera toxin: a macromolecule carrier with multiple activities. J Control Release. 343:551–563. doi:10.1016/j.jconrel.2022.01.050.
   PubMed Web of Science ®Google Scholar
• Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, et al. 2000. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 406(6795):477–483. doi:10.1038/35020000.
   PubMed Web of Science ®Google Scholar
• Hema M, Balasubramanian S, Princy SA. 2015. Meddling Vibrio cholerae murmurs: a neoteric advancement in cholera research. Indian J Microbiol. 55(2):121–130. doi:10.1007/s12088-015-0520-1.
   PubMed Web of Science ®Google Scholar
• Hema M, Princy SA, Sridharan V, Vinoth P, Balamurugan P, Sumana MN. 2016. Synergistic activity of quorum sensing inhibitor, pyrizine-2-carboxylic acid and antibiotics against multi-drug resistant V. cholerae. RSC Adv. 6(51):45938–45946. doi:10.1039/C6RA04705J.
   Web of Science ®Google Scholar
• Hema M, Vasudevan S, Balamurugan P, Adline Princy S. 2017. Modulating the global response regulator, LuxO of V. cholerae quorum sensing system using a pyrazine dicarboxylic acid derivative (PDCApy): an antivirulence approach. Front Cell Infect Microbiol. 7:441. doi:10.3389/fcimb.2017.00441.
   PubMed Web of Science ®Google Scholar
• Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, Levine MM. 1988. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med. 168(4):1487–1492. doi:10.1084/jem.168.4.1487.
   PubMed Web of Science ®Google Scholar
• Higgins DA, Pomianek ME, Kraml CM, Taylor RK, Semmelhack MF, Bassler BL. 2007. The major Vibrio cholerae autoinducer and its role in virulence factor production. Nature. 450(7171):883–886. doi:10.1038/nature06284.
   PubMed Web of Science ®Google Scholar
• Honma Y, Iwanaga M. 2006. Conservation of cholera toxin gene in a strain of cholera toxin non-producing Vibrio cholerae O1. FEMS Microbiol Lett. 154(1):111–116. doi:10.1111/j.1574-6968.1997.tb12631.x.
   Google Scholar
• Hsiao A, Zhu J. 2020. Pathogenicity and virulence regulation of Vibrio cholerae at the interface of host-gut microbiome interactions. Virulence. 11(1):1582–1599. doi:10.1080/21505594.2020.1845039.
   PubMed Web of Science ®Google Scholar
• Hunt DE, Gevers D, Vahora NM, Polz MF. 2008. Conservation of the chitin utilization pathway in the Vibrionaceae. Appl Environ Microbiol. 74(1):44–51. doi:10.1128/AEM.01412-07.
   PubMed Web of Science ®Google Scholar
• Ikigai H, Akatsuka A, Tsujiyama H, Nakae T, Shimamura T. 1996. Mechanism of membrane damage by El Tor hemolysin of Vibrio cholerae O1. Infect Immun. 64(8):2968–2973. doi:10.1128/iai.64.8.2968-2973.1996.
   PubMed Web of Science ®Google Scholar
• Islam MS, Islam MS, Mahmud ZH, Cairncross S, Clemens JD, Collins AE. 2015. Role of phytoplankton in maintaining endemicity and seasonality of cholera in Bangladesh. Trans R Soc Trop Med Hyg. 109(9):572–578. doi:10.1093/trstmh/trv057.
   PubMed Web of Science ®Google Scholar
• Jagdale S, Chandekar A. 2017. Optimization of chitosan and cellulose acetate phthalate controlled delivery of methylprednisolone for treatment of inflammatory bowel disease. Adv Pharm Bull. 7(2):203–213. doi:10.15171/apb.2017.025.
   PubMedGoogle Scholar
• Jana SK, Gucchait A, Paul S, Saha T, Acharya S, Hoque KM, Misra AK, Chatterjee BK, Chatterjee T, Chakrabarti P. 2021. Virstatin-conjugated gold nanoparticle with enhanced antimicrobial activity against the Vibrio cholerae El Tor biotype. ACS Appl Bio Mater. 4(4):3089–3100. doi:10.1021/acsabm.0c01483.
   PubMedGoogle Scholar
• Jermyn WS, Boyd EF. 2002. Characterization of a novel Vibrio pathogenicity island (VPI-2) encoding neuraminidase (nanH) among toxigenic Vibrio cholerae isolates. Microbiology (Reading). 148(Pt 11):3681–3693. doi:10.1099/00221287-148-11-3681.
   PubMedGoogle Scholar
• Jermyn WS, Boyd EF. 2005. Molecular evolution of Vibrio pathogenicity island-2 (VPI-2): mosaic structure among Vibrio cholerae and Vibrio mimicus natural isolates. Microbiology (Reading). 151(Pt 1):311–322. doi:10.1099/mic.0.27621-0.
   PubMedGoogle Scholar
• Joshi A, Kostiuk B, Rogers A, Teschler J, Pukatzki S, Yildiz FH. 2017. Rules of engagement: the type VI secretion system in Vibrio cholerae. Trends Microbiol. 25(4):267–279. doi:10.1016/j.tim.2016.12.003.
   PubMed Web of Science ®Google Scholar
• Jørgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR. 2008. Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae. J Biol Chem. 283(16):10671–10678. doi:10.1074/jbc.M710008200.
   PubMed Web of Science ®Google Scholar
• Jung SA, Chapman CA, Ng W-L. 2015. Quadruple Quorum-sensing inputs control Vibrio cholerae virulence and maintain system robustness. PLoS Pathog. 11(4):e1004837. doi:10.1371/journal.ppat.1004837.
   PubMed Web of Science ®Google Scholar
• Kanungo S, Azman AS, Ramamurthy T, Deen J, Dutta S. 2022. Cholera. Lancet. 399(10333):1429–1440. doi:10.1016/S0140-6736(22)00330-0.
   PubMed Web of Science ®Google Scholar
• Kaper JB, Morris JG, Levine MM. 1995. Cholera. Clin Microbiol Rev. 8(1):48–86. doi:10.1128/CMR.8.1.48.
   PubMed Web of Science ®Google Scholar
• Karaolis DKR, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. 1998. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci USA. 95(6):3134–3139. doi:10.1073/pnas.95.6.3134.
   PubMed Web of Science ®Google Scholar
• Karasawa T, Mihara T, Kurazono H, Nair GB, Garg S, Ramamurthy T, Takeda Y. 1993. Distribution of the zot (zonula occludens toxin) gene among strains of Vibrio cholerae 01 and non-01. FEMS Microbiol Lett. 106(2):143–145. doi:10.1111/j.1574-6968.1993.tb05950.x.
   PubMed Web of Science ®Google Scholar
• Kariisa AT, Grube A, Tamayo R. 2015. Two nucleotide second messengers regulate the production of the Vibrio cholerae colonization factor GbpA. BMC Microbiol. 15(1):166. doi:10.1186/s12866-015-0506-5.
   PubMedGoogle Scholar
• Karlsson SL, Thomson N, Mutreja A, Connor T, Sur D, Ali M, Clemens J, Dougan G, Holmgren J, Lebens M. 2016. Retrospective analysis of serotype switching of Vibrio cholerae O1 in a cholera endemic region shows it is a non-random process. PLoS Negl Trop Dis. 10(10):e0005044. doi:10.1371/journal.pntd.0005044.
   PubMed Web of Science ®Google Scholar
• Kathuria R, Chattopadhyay K. 2018. Vibrio cholerae cytolysin: multiple facets of the membrane interaction mechanism of a β -barrel pore-forming toxin. IUBMB Life. 70(4):260–266. doi:10.1002/iub.1725.
   PubMed Web of Science ®Google Scholar
• Khan AI, Ali M, Lynch J, Kabir A, Excler JL, Khan MA, Islam MT, Akter A, Chowdhury F, Saha A, et al. 2019. Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial. BMC Infect Dis. 19(1):422. doi:10.1186/s12879-019-4006-3.
   PubMedGoogle Scholar
• Kirn TJ, Jude BA, Taylor RK. 2005. A colonization factor links Vibrio cholerae environmental survival and human infection. Nature. 438(7069):863–866. doi:10.1038/nature04249.
   PubMed Web of Science ®Google Scholar
• Klose KE, Mekalanos JJ. 1998a. Differential regulation of multiple Flagellins in Vibrio cholerae. J Bacteriol. 180(2):303–316. doi:10.1128/JB.180.2.303-316.1998.
   PubMed Web of Science ®Google Scholar
• Klose KE, Mekalanos JJ. 1998b. Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle. Mol Microbiol. 28(3):501–520. doi:10.1046/j.1365-2958.1998.00809.x.
   PubMed Web of Science ®Google Scholar
• Kojima S, Yamamoto K, Kawagishi I, Homma M. 1999. The polar flagellar motor of Vibrio cholerae is driven by an Na+ motive force. J Bacteriol. 181(6):1927–1930. doi:10.1128/JB.181.6.1927-1930.1999.
   PubMed Web of Science ®Google Scholar
• Kratz F, Elsadek B. 2012. Clinical impact of serum proteins on drug delivery. J Control Release. 161(2):429–445. doi:10.1016/j.jconrel.2011.11.028.
   PubMed Web of Science ®Google Scholar
• Krukonis ES, DiRita VJ. 2003. From motility to virulence: sensing and responding to environmental signals in Vibrio cholerae. Curr Opin Microbiol. 6(2):186–190. doi:10.1016/S1369-5274(03)00032-8.
   PubMed Web of Science ®Google Scholar
• Krukonis ES, Yu RR, DiRita VJ. 2000. The Vibrio cholerae ToxR/TcpP/ToxT virulence cascade: distinct roles for two membrane-localized transcriptional activators on a single promoter. Mol Microbiol. 38(1):67–84. doi:10.1046/j.1365-2958.2000.02111.x.
   PubMed Web of Science ®Google Scholar
• Kumar A, Das B, Kumar N. 2020. Vibrio Pathogenicity Island-1: the master determinant of cholera pathogenesis. Front Cell Infect Microbiol. 10:561296. doi:10.3389/fcimb.2020.561296.
   PubMed Web of Science ®Google Scholar
• Kumar H, Kawai T, Akira S. 2011. Pathogen recognition by the innate immune system. Int Rev Immunol. 30(1):16–34. doi:10.3109/08830185.2010.529976.
   PubMed Web of Science ®Google Scholar
• Lee BK, Yun YH, Park K. 2015. Smart nanoparticles for drug delivery: boundaries and opportunities. Chem Eng Sci. 125:158–164. doi:10.1016/j.ces.2014.06.042.
   PubMed Web of Science ®Google Scholar
• Lee SH, Hava DL, Waldor MK, Camilli A. 1999. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell. 99(6):625–634. doi:10.1016/S0092-8674(00)81551-2.
   PubMed Web of Science ®Google Scholar
• Levine MM, Kaper JB, Herrington D, Losonsky G, Morris JG, Clements ML, Black RE, Tall B, Hall R. 1988. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun. 56(1):161–167. doi:10.1128/iai.56.1.161-167.1988.
   PubMed Web of Science ®Google Scholar
• Li M, Shimada T, Morris JG, Sulakvelidze A, Sozhamannan S. 2002. Evidence for the emergence of non-o1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun. 70(5):2441–2453. doi:10.1128/IAI.70.5.2441-2453.2002.
   PubMed Web of Science ®Google Scholar
• Lin W, Fullner KJ, Clayton R, Sexton JA, Rogers MB, Calia KE, Calderwood SB, Fraser C, Mekalanos JJ. 1999. Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci USA. 96(3):1071–1076. doi:10.1073/pnas.96.3.1071.
   PubMed Web of Science ®Google Scholar
• Lin W, Kovacikova G, Skorupski K. 2007. The quorum sensing regulator HapR downregulates the expression of the virulence gene transcription factor AphA in Vibrio cholerae by antagonizing Lrp- and VpsR-mediated activation. Mol Microbiol. 64(4):953–967. doi:10.1111/j.1365-2958.2007.05693.x.
   PubMed Web of Science ®Google Scholar
• Lüderitz O, Staub AM, Westphal O. 1966. Immunochemistry of O and R antigens of Salmonella and related Entero­bacteriaceae. Bacteriol Rev. 30(1):192–255. doi:10.1128/br.30.1.192-255.1966.
   PubMedGoogle Scholar
• Mashruwala AA, Bassler BL. 2020. The Vibrio cholerae Quorum-sensing protein VqmA integrates cell density, environmental, and host-derived cues into the control of virulence. MBio. 11(4):20. doi:10.1128/mBio.01572-20.
   Web of Science ®Google Scholar
• McCarter LL. 2001. Polar flagellar motility of the Vibrionaceae. Microbiol Mol Biol Rev. 65(3):445–462, table of contents. doi:10.1128/MMBR.65.3.445-462.2001.
   PubMed Web of Science ®Google Scholar
• Meibom KL, Li XB, Nielsen AT, Wu CY, Roseman S, Schoolnik GK. 2004. The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci USA. 101(8):2524–2529. doi:10.1073/pnas.0308707101.
   PubMed Web of Science ®Google Scholar
• Miller KA, Tomberlin KF, Dziejman M. 2019. Vibrio variations on a type three theme. Curr Opin Microbiol. 47:66–73. doi:10.1016/j.mib.2018.12.001.
   PubMed Web of Science ®Google Scholar
• Miller VL, Mekalanos JJ. 1984. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc Natl Acad Sci USA. 81(11):3471–3475. doi:10.1073/pnas.81.11.3471.
   PubMed Web of Science ®Google Scholar
• Millet YA, Alvarez D, Ringgaard S, von Andrian UH, Davis BM, Waldor MK. 2014. Insights into Vibrio cholerae intestinal colonization from monitoring fluorescently labeled bacteria. PLoS Pathog. 10(10):e1004405. doi:10.1371/journal.ppat.1004405.
   PubMed Web of Science ®Google Scholar
• Mondal AK, Sengupta N, Singh M, Biswas R, Lata K, Lahiri I, Dutta S, Chattopadhyay K. 2022. Glu289 residue in the pore-forming motif of Vibrio cholerae cytolysin is important for efficient β-barrel pore formation. J Biol Chem. 298(10):102441. doi:10.1016/j.jbc.2022.102441.
   PubMed Web of Science ®Google Scholar
• Muller A. 1999. Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. The EMBO J. 18(2):339–352. doi:10.1093/emboj/18.2.339.
   PubMed Web of Science ®Google Scholar
• Mutreja A, Kim DW, Thomson NR, Connor TR, Lee JH, Kariuki S, Croucher NJ, Choi SY, Harris SR, Lebens M, et al. 2011. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 477(7365):462–465. doi:10.1038/nature10392.
   PubMed Web of Science ®Google Scholar
• Nagamune K, Yamamoto K, Naka A, Matsuyama J, Miwatani T, Honda T. 1996. In vitro proteolytic processing and activation of the recombinant precursor of El Tor cytolysin/hemolysin (pro-HlyA) of Vibrio cholerae by soluble hemagglutinin/protease of V. cholerae, trypsin, and other proteases. Infect Immun. 64(11):4655–4658. doi:10.1128/iai.64.11.4655-4658.1996.
   PubMed Web of Science ®Google Scholar
• Naha A, Chowdhury G, Ghosh-Banerjee J, Senoh M, Takahashi T, Ley B, Thriemer K, Deen J, Seidlein LV, Ali SM, et al. 2013. Molecular characterization of high-level-cholera-toxin-producing El Tor variant Vibrio cholerae strains in the Zanzibar archipelago of Tanzania. J Clin Microbiol. 51(3):1040–1045. Mar doi:10.1128/JCM.03162-12.
   PubMed Web of Science ®Google Scholar
• Nair GB, Ramamurthy T, Bhattacharya SK, Mukhopadhyay AK, Garg S, Bhattacharya MK, Takeda T, Shimada T, Takeda Y, Deb BC. 1994. Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis. 169(5):1029–1034. doi:10.1093/infdis/169.5.1029.
   PubMed Web of Science ®Google Scholar
• Nardini M, Dijkstra BW. 1999. α/β hydrolase fold enzymes: the family keeps growing. Curr Opin Struct Biol. 9(6):732–737. doi:10.1016/S0959-440X(99)00037-8.
   PubMed Web of Science ®Google Scholar
• Narendrakumar L, Gupta SS, Johnson JB, Ramamurthy T, Thomas S. 2019a. Molecular adaptations and antibiotic resistance in Vibrio cholerae: a communal challenge. Microb Drug Resist. 25(7):1012–1022. doi:10.1089/mdr.2018.0354.
   PubMed Web of Science ®Google Scholar
• Narendrakumar L, Theresa M, Krishnankutty Chandrika S, Thomas S. 2019b. Tryptanthrin, a potential biofilm inhibitor against toxigenic Vibrio cholerae, modulating the global quorum sensing regulator, LuxO. Biofouling. 35(10):1093–1103. doi:10.1080/08927014.2019.1696315.
   PubMed Web of Science ®Google Scholar
• Negm RS, Pistole TG. 1999. The porin OmpC of Salmonella typhimurium mediates adherence to macrophages. Can J Microbiol. 45(8):658–669. doi:10.1139/w99-053.
   PubMed Web of Science ®Google Scholar
• Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 67(4):593–656. doi:10.1128/MMBR.67.4.593-656.2003.
   PubMed Web of Science ®Google Scholar
• Nikaido H, Takatsuka Y. 2009. Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta. 1794(5):769–781. doi:10.1016/j.bbapap.2008.10.004.
   PubMed Web of Science ®Google Scholar
• Ogura K, Yahiro K, Moss J. 2020. Cell death signaling pathway induced by cholix toxin, a cytotoxin and eEF2 ADP-Ribosyltransferase produced by Vibrio cholerae. Toxins. 13(1):12. doi:10.3390/toxins13010012.
   PubMed Web of Science ®Google Scholar
• Olivier V, Haines GK, Tan Y, Satchell KJF. 2007. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains. Infect Immun. 75(10):5035–5042. doi:10.1128/IAI.00506-07.
   PubMed Web of Science ®Google Scholar
• Papenfort K, Silpe JE, Schramma KR, Cong J-P, Seyedsayamdost MR, Bassler BL. 2017. A Vibrio cholerae autoinducer–receptor pair that controls biofilm formation. Nat Chem Biol. 13(5):551–557. doi:10.1038/nchembio.2336.
   PubMed Web of Science ®Google Scholar
• Peach KC, Cheng AT, Oliver AG, Yildiz FH, Linington RG. 2013. Discovery and biological characterization of the auromomycin chromophore as an inhibitor of biofilm formation in Vibrio cholerae. Chembiochem. 14(16):2209–2215. doi:10.1002/cbic.201300131.
   PubMed Web of Science ®Google Scholar
• Pei J, Grishin NV. 2009. The Rho GTPase inactivation domain in Vibrio cholerae MARTX toxin has a circularly permuted papain-like thiol protease fold. Proteins Struct Funct Bioinf. 77(2):413–419. doi:10.1002/prot.22447.
   PubMed Web of Science ®Google Scholar
• Peterson KM, Mekalanos JJ. 1988. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect Immun. 56(11):2822–2829. doi:10.1128/iai.56.11.2822-2829.1988.
   PubMed Web of Science ®Google Scholar
• Plecha SC, Withey JH. 2015. Mechanism for inhibition of Vibrio cholerae ToxT activity by the unsaturated fatty acid components of bile. J Bacteriol. 197(10):1716–1725. doi:10.1128/JB.02409-14.
   PubMed Web of Science ®Google Scholar
• Priya James H, John R, Alex A, Anoop KR. 2014. Smart polymers for the controlled delivery of drugs – a concise overview. Acta Pharm Sin B. 4(2):120–127. doi:10.1016/j.apsb.2014.02.005.
   PubMed Web of Science ®Google Scholar
• Prouty MG, Correa NE, Klose KE. 2001. The novel sigma54- and sigma28-dependent flagellar gene transcription hierarchy of Vibrio cholerae. Mol Microbiol. 39(6):1595–1609. doi:10.1046/j.1365-2958.2001.02348.x.
   PubMed Web of Science ®Google Scholar
• Ramamurthy T, Nandy RK, Mukhopadhyay AK, Dutta S, Mutreja A, Okamoto K, Miyoshi S-I, Nair GB, Ghosh A. 2020. Virulence regulation and innate host response in the pathogenicity of Vibrio cholerae. Front Cell Infect Microbiol. 10:572096. doi:10.3389/fcimb.2020.572096.
   PubMed Web of Science ®Google Scholar
• Rashed SM, Hasan NA, Alam M, Sadique A, Sultana M, Hoq MM, Sack RB, Colwell RR, Huq A. 2017. Vibrio cholerae O1 with reduced susceptibility to ciprofloxacin and azithromycin isolated from a rural coastal area of Bangladesh. Front Microbiol. 8:252. doi:10.3389/fmicb.2017.00252.
   PubMed Web of Science ®Google Scholar
• Rasko DA, Sperandio V. 2010. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov. 9(2):117–128. doi:10.1038/nrd3013.
   PubMed Web of Science ®Google Scholar
• Reguera G, Kolter R. 2005. Virulence and the environment: a novel role for Vibrio cholerae toxin-coregulated pili in biofilm formation on chitin. J Bacteriol. 187(10):3551–3555. doi:10.1128/JB.187.10.3551-3555.2005.
   PubMed Web of Science ®Google Scholar
• Reidl J, Klose KE. 2002. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev. 26(2):125–139. doi:10.1111/j.1574-6976.2002.tb00605.x.
   PubMed Web of Science ®Google Scholar
• Rezzoagli C, Archetti M, Mignot I, Baumgartner M, Kümmerli R. 2020. Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa. PLoS Biol. 18(8):e3000805. doi:10.1371/journal.pbio.3000805.
   PubMed Web of Science ®Google Scholar
• Rutherford ST, van Kessel JC, Shao Y, Bassler BL. 2011. AphA and LuxR/HapR reciprocally control quorum sensing in vibrios. Genes Dev. 25(4):397–408. doi:10.1101/gad.2015011.
   PubMed Web of Science ®Google Scholar
• Safa A, Jime JS, Shahel F. 2020. Cholera toxin phage: structural and functional diversity between Vibrio cholerae biotypes. AIMS Microbiol. 6(2):144–151. doi:10.3934/microbiol.2020009.
   PubMed Web of Science ®Google Scholar
• Sakib SN, Reddi G, Almagro-Moreno S. 2018. Environmental role of pathogenic traits in Vibrio cholerae. J Bacteriol. 200(15):17. doi:10.1128/JB.00795-17.
   Web of Science ®Google Scholar
• Saha S, Aggarwal S, Singh DV. 2023. Attenuation of quorum sensing system and virulence in Vibrio cholerae by phytomolecules. Front Microbiol. 14:1133569. doi:10.3389/fmicb.2023.1133569.
   PubMed Web of Science ®Google Scholar
• Salama NN, Eddington ND, Fasano A. 2006. Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev. 58(1):15–28. doi:10.1016/j.addr.2006.01.003.
   PubMed Web of Science ®Google Scholar
• Singh M, Rupesh N, Pandit SB, Chattopadhyay K. 2021. Curcumin inhibits membrane-damaging pore-forming function of the β-barrel pore-forming toxin Vibrio cholerae cytolysin. Front Microbiol. 12:809782. doi:10.3389/fmicb.2021.809782.
   PubMed Web of Science ®Google Scholar
• Sarker AR, Islam Z, Sultana M, Sheikh N, Mahumud RA, Islam MT, Meer RV, Der Morton A, Khan AI, Clemens JD, et al. 2020. Willingness to pay for oral cholera vaccines in urban Bangladesh. PLoS One. 15(4):e0232600. doi:10.1371/journal.pone.0232600.
   PubMed Web of Science ®Google Scholar
• Sarveswari HB, Gupta KK, Durai R, Solomon AP. 2023. Development of a smart pH-responsive nano-polymer drug, 2-methoxy-4-vinylphenol conjugate against the intestinal pathogen, Vibrio cholerae. Sci Rep. 13(1):1250. doi:10.1038/s41598-023-28033-0.
   PubMed Web of Science ®Google Scholar
• Sarveswari HB, Kalimuthu S, Shanmugam K, Neelakantan P, Solomon AP. 2020. Exploration of Anti-infectives from mangrove-derived micromonospora sp. RMA46 to combat Vibrio cholerae pathogenesis. Front Microbiol. 11:1393. doi:10.3389/fmicb.2020.01393.
   PubMed Web of Science ®Google Scholar
• Sarwar S, Chakraborti S, Bera S, Sheikh IA, Hoque KM, Chakrabarti P. 2016. The antimicrobial activity of ZnO nanoparticles against Vibrio cholerae : Variation in response depends on biotype. Nanomedicine. 12(6):1499–1509. doi:10.1016/j.nano.2016.02.006.
   PubMed Web of Science ®Google Scholar
• Shakhnovich EA, Hung DT, Pierson E, Lee K, Mekalanos JJ. 2007. Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci USA. 104(7):2372–2377. doi:10.1073/pnas.0611643104.
   PubMed Web of Science ®Google Scholar
• Shao Y, Bassler BL. 2012. Quorum-sensing non-coding small RNAs use unique pairing regions to differentially control mRNA targets. Mol Microbiol. 83(3):599–611. doi:10.1111/j.1365-2958.2011.07959.x.
   PubMed Web of Science ®Google Scholar
• Siddique AK, Nair GB, Alam M, Sack DA, Huq A, Nizam A, Longini IM, Jr.Qadri F, Faruque SM, Colwell RR, et al. 2010. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect. 138(3):347–352. doi:10.1017/S0950268809990550.
   PubMed Web of Science ®Google Scholar
• Silva AJ, Benitez JA. 2016. Vibrio cholerae biofilms and cholera pathogenesis. PLoS Negl Trop Dis. 10(2):e0004330. doi:10.1371/journal.pntd.0004330.
   PubMed Web of Science ®Google Scholar
• Silva AJ, Pham K, Benitez JA. 2003. Haemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology. 149(Pt 7):1883–1891. doi:10.1099/mic.0.26086-0.
   PubMedGoogle Scholar
• Singh PK, Bartalomej S, Hartmann R, Jeckel H, Vidakovic L, Nadell CD, Drescher K. 2017. Vibrio cholerae combines individual and collective sensing to trigger biofilm dispersal. Curr Biol. 27(21):3359–3366.e7. doi:10.1016/j.cub.2017.09.041.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Kumria R. 2003. Microbially triggered drug delivery to the colon. Eur J Pharm Sci. 18(1):3–18. doi:10.1016/s0928-0987(02)00221-x.
   PubMed Web of Science ®Google Scholar
• Sit B, Fakoya B, Waldor MK. 2022. Emerging concepts in cholera vaccine design. Annu Rev Microbiol. 76(1):681–702. doi:10.1146/annurev-micro-041320-033201.
   PubMedGoogle Scholar
• Sorci G, Faivre B. 2009. Inflammation and oxidative stress in vertebrate host–parasite systems. Philos Trans R Soc Lond B Biol Sci. 364(1513):71–83. doi:10.1098/rstb.2008.0151.
   PubMed Web of Science ®Google Scholar
• Sperandio V, Girón JA, Silveira WD, Kaper JB. 1995. The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae. Infect Immun. 63(11):4433–4438. doi:10.1128/iai.63.11.4433-4438.1995.
   PubMed Web of Science ®Google Scholar
• Syed KA, Beyhan S, Correa N, Queen J, Liu J, Peng F, Satchell KJF, Yildiz F, Klose KE. 2009. The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors. J Bacteriol. 191(21):6555–6570. doi:10.1128/JB.00949-09.
   PubMed Web of Science ®Google Scholar
• Tarsi R, Pruzzo C. 1999. Role of surface proteins in Vibrio cholerae attachment to chitin. Appl Environ Microbiol. 65(3):1348–1351. doi:10.1128/AEM.65.3.1348-1351.1999.
   PubMed Web of Science ®Google Scholar
• Thanassi DG, Cheng LW, Nikaido H. 1997. Active efflux of bile salts by Escherichia coli. J Bacteriol. 179(8):2512–2518. doi:10.1128/jb.179.8.2512-2518.1997.
   PubMed Web of Science ®Google Scholar
• Theuretzbacher U, Outterson K, Engel A, Karlén A. 2020. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 18(5):275–285. doi:10.1038/s41579-019-0288-0.
   PubMed Web of Science ®Google Scholar
• Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. 1993. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci USA. 90(11):5267–5271. doi:10.1073/pnas.90.11.5267.
   PubMed Web of Science ®Google Scholar
• Valiente E, Davies C, Mills DC, Getino M, Ritchie JM, Wren BW. 2018. Vibrio cholerae accessory colonisation factor AcfC: a chemotactic protein with a role in hyper infectivity. Sci Rep. 8(1):8390. doi:10.1038/s41598-018-26570-7.
   PubMedGoogle Scholar
• Vanden Broeck D, Horvath C, De Wolf MJS. 2007. Vibrio cholerae: cholera toxin. Int J Biochem Cell Biol. 39(10):1771–1775. doi:10.1016/j.biocel.2007.07.005.
   PubMed Web of Science ®Google Scholar
• Verma J, Bag S, Saha B, Kumar P, Ghosh TS, Dayal M, Senapati T, Mehra S, Dey P, Desigamani A, et al. 2019. Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae. Proc Natl Acad Sci USA. 116(13):6226–6231. doi:10.1073/pnas.1900141116.
   PubMed Web of Science ®Google Scholar
• Villeneuve S, Boutonnier A, Mulard LA, Fournier J-M. 1999. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1. Microbiology. 145(Pt 9):2477–2484. doi:10.1099/00221287-145-9-2477.
   PubMedGoogle Scholar
• Waldor MK, Mekalanos JJ. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 272(5270):1910–1914. doi:10.1126/science.272.5270.1910.
   PubMed Web of Science ®Google Scholar
• Wang BX, Takagi J, McShane A, Park JH, Aoki K, Griffin C, Teschler J, Kitts G, Minzer G, Tiemeyer M, et al. 2023. Host-derived O-glycans inhibit toxigenic conversion by a virulence-encoding phage in Vibrio cholerae. Embo J. 42(3):e111562. doi:10.15252/embj.2022111562.
   PubMed Web of Science ®Google Scholar
• Wang Z, Guo J, Liu X, Sun J, Gao W. 2020. Temperature-triggered micellization of interferon alpha-diblock copolypeptide conjugate with enhanced stability and pharmacology. J Control Release. 328:444–453. doi:10.1016/j.jconrel.2020.08.065.
   PubMed Web of Science ®Google Scholar
• Warner CJA, Cheng AT, Yildiz FH, Linington RG. 2015. Development of benzo[1,4]oxazines as biofilm inhibitors and dispersal agents against Vibrio cholerae. Chem Commun. 51(7):1305–1308. doi:10.1039/C4CC07003H.
   PubMed Web of Science ®Google Scholar
• Waters RC, O’Toole PW, Ryan KA. 2007. The FliK protein and flagellar hook-length control. Protein Sci. 16(5):769–780. doi:10.1110/ps.072785407.
   PubMed Web of Science ®Google Scholar
• Watnick PI, Fullner KJ, Kolter R. 1999. A role for the mannose-sensitive hemagglutinin in biofilm formation by Vibrio cholerae El Tor. J Bacteriol. 181(11):3606–3609. doi:10.1128/JB.181.11.3606-3609.1999.
   PubMed Web of Science ®Google Scholar
• Wibbenmeyer JA, Provenzano D, Landry CF, Klose KE, Delcour AH. 2002. Vibrio cholerae OmpU and OmpT porins are differentially affected by bile. Infect Immun. 70(1):121–126. doi:10.1128/IAI.70.1.121-126.2002.
   PubMed Web of Science ®Google Scholar
• Wierzba TF. 2019. Oral cholera vaccines and their impact on the global burden of disease. Hum Vaccin Immunother. 15(6):1294–1301. doi:10.1080/21645515.2018.1504155.
   PubMed Web of Science ®Google Scholar
• Withey JH, DiRita VJ. 2005. Activation of both acfA and acfD transcription by Vibrio cholerae ToxT requires binding to two centrally located DNA sites in an inverted repeat conformation. Mol Microbiol. 56(4):1062–1077. doi:10.1111/j.1365-2958.2005.04589.x.
   PubMed Web of Science ®Google Scholar
• Woida PJ, Satchell KJF. 2020. The Vibrio cholerae MARTX toxin silences the inflammatory response to cytoskeletal damage before inducing actin cytoskeleton collapse. Sci Signal. 13(614):447. doi:10.1126/scisignal.aaw9447.
   Web of Science ®Google Scholar
• Woodbrey AK, Onyango EO, Kovacikova G, Kull FJ, Gribble GW. 2018. A modified ToxT inhibitor reduces Vibrio cholerae virulence in vivo. Biochemistry. 57(38):5609–5615. doi:10.1021/acs.biochem.8b00667.
   PubMed Web of Science ®Google Scholar
• Xu Q, Dziejman M, Mekalanos JJ. 2003. Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and mid-exponential phase in vitro. Proc Natl Acad Sci USA. 100(3):1286–1291. doi:10.1073/pnas.0337479100.
   PubMed Web of Science ®Google Scholar
• Yan J, Sharo AG, Stone HA, Wingreen NS, Bassler BL. 2016. Vibrio cholerae biofilm growth program and architecture revealed by single-cell live imaging. Proc Natl Acad Sci USA. 36:113. doi:10.1073/pnas.1611494113.
   Google Scholar
• Yang M, Frey EM, Liu Z, Bishar R, Zhu J. 2010. The virulence transcriptional activator Apha enhances biofilm formation by Vibrio cholerae by activating expression of the biofilm regulator VpsT. Infect Immun. 78(2):697–703. doi:10.1128/IAI.00429-09.
   PubMed Web of Science ®Google Scholar
• Yu C, Lee AM, Bassler BL, Roseman S. 1991. Chitin utilization by marine bacteria. A physiological function for bacterial adhesion to immobilized carbohydrates. J Biol Chem. 266(36):24260–24267. doi:10.1016/S0021-9258(18)54223-X.
   PubMed Web of Science ®Google Scholar
• Zahid MSH, Awasthi SP, Asakura M, Chatterjee S, Hinenoya A, Faruque SM, Yamasaki S. 2015. Suppression of virulence of toxigenic Vibrio cholerae by anethole through the cyclic AMP (cAMP)-cAMP receptor protein signaling system. PLoS One. 10(9):e0137529. doi:10.1371/journal.pone.0137529.
   PubMed Web of Science ®Google Scholar
• Zhang W, Luo M, Feng C, Liu H, Zhang H, Bennett RR, Utada AS, Liu Z, Zhao K. 2021a. Crash landing of Vibrio cholerae by MSHA pili-assisted braking and anchoring in a viscoelastic environment. Elife. 10:655. doi:10.7554/eLife.60655.
   Web of Science ®Google Scholar
• Zhang X, Han Y, Huang W, Jin M, Gao Z. 2021b. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B. 11(7):1789–1812. doi:10.1016/j.apsb.2020.09.013.
   PubMed Web of Science ®Google Scholar
• Zheng J, Shin OS, Cameron DE, Mekalanos JJ. 2010. Quorum sensing and a global regulator TsrA control expression of type VI secretion and virulence in Vibrio cholerae. Proc Natl Acad Sci USA. 107(49):21128–21133. doi:10.1073/pnas.1014998107.
   PubMed Web of Science ®Google Scholar
• Zhu J, Mekalanos JJ. 2003. Quorum sensing-dependent biofilms enhance colonization in Vibrio cholerae. Dev Cell. 5(4):647–656. doi:10.1016/s1534-5807(03)00295-8.
   PubMed Web of Science ®Google Scholar
• Zitzer A, Wassenaar TM, Walev I, Bhakdi S. 1997. Potent membrane-permeabilizing and cytocidal action of Vibrio cholerae cytolysin on human intestinal cells. Infect Immun. 65(4):1293–1298. doi:10.1128/iai.65.4.1293-1298.1997.
   PubMed Web of Science ®Google Scholar